Saad Elzanaty1, Claus Erik Johansen2. 1. Department of Urology, Ystad Hospital, Ystad, Sweden ; Department of Urology, Lund University, Ystad, Sweden. 2. Department of Radiology, Ystad Hospital, Ystad, Sweden.
Abstract
INTRODUCTION: The aim of the present study was to evaluate the effectiveness of microsurgical varicocele repair in patients with grade III lesions and chronic dull scrotal pain. MATERIALS AND METHODS: The study was based on 8 patients with grade III left-sided varicocele and chronic dull scrotal pain for whom a microsurgical subinguinal varicocele repair was performed. The 1-year follow-up included pain assessment and scrotal examination. RESULTS: Of the 8 patients, 7 (88%) reported complete resolution of pain with no palpable varicocele on scrotal examination. No cases of testicular atrophy or hydrocele formation were reported. CONCLUSION: These results indicated that microsurgical varicocele repair may benefit patients with grade III lesions and chronic dull scrotal pain.
INTRODUCTION: The aim of the present study was to evaluate the effectiveness of microsurgical varicocele repair in patients with grade III lesions and chronic dull scrotal pain. MATERIALS AND METHODS: The study was based on 8 patients with grade III left-sided varicocele and chronic dull scrotal pain for whom a microsurgical subinguinal varicocele repair was performed. The 1-year follow-up included pain assessment and scrotal examination. RESULTS: Of the 8 patients, 7 (88%) reported complete resolution of pain with no palpable varicocele on scrotal examination. No cases of testicular atrophy or hydrocele formation were reported. CONCLUSION: These results indicated that microsurgical varicocele repair may benefit patients with grade III lesions and chronic dull scrotal pain.
Authors: Paul Diegidio; Jay K Jhaveri; Suzanne Ghannam; Ruben Pinkhasov; Ridwan Shabsigh; Harry Fisch Journal: BJU Int Date: 2011-03-24 Impact factor: 5.588
Authors: Keith A Jarvi; Christopher Wu; J Curtis Nickel; Trustin Domes; John Grantmyre; Armand Zini Journal: Can Urol Assoc J Date: 2018-02-23 Impact factor: 1.862